動物用抗生物質・抗菌薬市場：製品、投与方法、形態、動物タイプ別-2025～2030年世界予測

動物用抗生物質・抗菌薬市場は、2023年に6億3,551万米ドルと評価され、2024年には6億6,723万米ドルに達すると予測され、CAGR 5.25%で成長し、2030年には9億984万米ドルに達すると予測されています。

動物用抗生物質・抗菌薬市場は、動物の微生物感染の予防と治療を明確に目的とした製品によって定義され、それによって動物の健康を確保し、食料生産のための家畜の生産性を向上させる。この市場は、動物集団における疾病蔓延リスクの高まり、成長率と飼料効率を高める必要性、動物由来の食品に対する世界の需要の増大によって必要とされています。その用途は獣医療、家畜管理、ペットケア、水産養殖にまたがり、エンドユーザーは農業従事者や獣医師から製薬メーカーまで多岐にわたります。市場成長の原動力は、動物の健康問題に対する意識の高まり、獣医療の進歩、世界の食肉消費の拡大です。しかし、特にアジア太平洋や南米など、都市化と同時に畜産業が拡大している新興国にも大きなビジネス機会があります。成長に影響を与える主要要因としては、抗菌剤や代替製品の技術革新、抗生物質の使用削減を奨励する規制の枠組み、獣医医療への投資の増加などが挙げられます。逆に、市場成長は、厳しい規制、抗生物質耐性懸念の高まり、抗生物質不使用や有機農法への支持の高まりといった課題に直面しています。分子診断や精密医療によるオーダーメイド治療の革新と、プロバイオティクスやハーブ系抗菌薬などの代替製品の開発は、事業拡大の可能性を示しています。市場の性質に関する動向から、持続可能性とコンプライアンスを確保するために、食品サプライチェーン全体にわたる協働を伴う統合的健康管理ソリューションへの傾向が明らかになります。規制の変化への対応、新規かつサステイナブル製品の研究開発への投資、動物用医薬品全般にわたる利害関係者との戦略的パートナーシップの強化は、市場課題を克服しつつ成長の可能性を最適化するために推奨される戦略です。全体として、今後の展望は、動物用医薬品による健康ソリューションの進展と抗菌薬耐性に関連する公衆衛生上の懸念の緩和とのバランスを強調するものです。

市場力学：急速に進化する動物用抗生物質・抗菌薬市場の主要市場洞察を公開

動物用抗生物質・抗菌薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 畜産物需要の増加とペニシリン系抗生物質に対する旺盛な需要
  • 家畜伝染病対策への政府の関与の増加
  • 動物性疾患治療開発のための莫大な資本投資の増加
• 市場抑制要因
  • 抗生物質に対する耐性に関する懸念厳しい規制当局の承認
• 市場機会
  • 最先端の研究開発施設と新薬開発活動の加速化
  • 新規抗菌薬の持続可能性への注目の高まり
• 市場課題
  • 代替品の入手可能性

ポーターのファイブフォース：動物用抗生物質・抗菌薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用抗生物質・抗菌薬市場における外部からの影響の把握

外部マクロ環境要因は、動物用抗生物質・抗菌薬市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：動物用抗生物質・抗菌薬市場における競合情勢の把握

動物用抗生物質・抗菌薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：動物用抗生物質・抗菌薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用抗生物質・抗菌薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：動物用抗生物質・抗菌薬市場における成功への道筋を描く

動物用抗生物質・抗菌薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 畜産物の需要増加とペニシリン系抗生物質の需要増加
    • 動物の病気の発生への対策における政府の関与の強化
    • 動物の病気の治療開発への巨額の資本投資増加
  • 抑制要因
    • 抗生物質に対する耐性に関する懸念厳格な規制承認
  • 機会
    • 先端研究開発施設と新薬開発活動の加速
    • 新しい抗菌剤の持続可能性への注目が高まる
  • 課題
    • 代替品の入手可能性
• 市場セグメンテーション分析
  • 製品：病気の予防と治療のための抗生物質の需要の高まり
  • 投与方法：非侵襲的な処置であるため、経口投与への傾向が高まっている
  • 形態：重度の細菌感染症に罹患した個々の動物の治療に抗菌溶液の使用が増加
  • 動物タイプ：細菌感染を管理するために、ペット動物における抗生物質と抗菌剤の需要が拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 動物用抗生物質・抗菌薬市場：製品別

• イントロダクション
• 抗生物質
• 抗菌性

第7章 動物用抗生物質・抗菌薬市場：投与方法別

• イントロダクション
• 注射
• 経口

第8章 動物用抗生物質・抗菌薬市場：形態別

• イントロダクション
• 粉末と錠剤
• 溶液

第9章 動物用抗生物質・抗菌薬市場：動物タイプ別

• イントロダクション
• コンパニオンアニマル
  • 猫
  • 犬
  • 馬
• 食用動物
  • 牛
  • 豚
  • 家禽
  • 羊とヤギ

第10章 南北アメリカの動物用抗生物質・抗菌薬市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の動物用抗生物質・抗菌薬市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用抗生物質・抗菌薬市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Zoetisは米国でリブレラ（ベディンベトマブ注射剤）の商業発売により犬におけるイノベーションを実証
  • Huvepharma、FDA承認の唯一のトリプルサルファ剤を米国市場に復帰
  • ElancoとGinkgo Bioworksがマイクロバイオーム技術を活用した新しい動物医療会社BiomEditを設立
• 戦略分析と提言

企業一覧

• American Regent Inc.
• Ayurvet
• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Chanelle Pharma
• Dechra Pharmaceuticals PLC
• Eco Animal Health Group PLC
• Elanco Animal Health Incorporated
• Eli Lilly and Company
• Endovac Animal Health, LLC
• Hester Biosciences Limited
• Hipra Laboratories, S.A.
• Inovet Group
• Neogen Corporation
• Norbrook Laboratories Ltd.
• Novartis AG
• Phibro Animal Health Corporation
• Sanofi-Aventis Groupe S.A.
• Tianjin Ringpu BIoTechnology Co., Ltd.
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis, Inc.
• Zydus Pharmaceuticals, Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POWDERS & TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 50. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 51. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 79. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 81. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 82. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 83. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 84. CHINA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 85. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 87. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 88. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 89. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 188. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 190. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 191. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 192. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 193. ITALY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 212. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 214. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 215. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 216. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 217. POLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 218. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 220. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 221. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 222. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 223. QATAR ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TYPE OF ANIMAL, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2018-2030 (USD MILLION)
• TABLE 278. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 279. ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2023

The Animal Antibiotics & Antimicrobials Market was valued at USD 635.51 million in 2023, expected to reach USD 667.23 million in 2024, and is projected to grow at a CAGR of 5.25%, to USD 909.84 million by 2030.

The Animal Antibiotics & Antimicrobials market is defined by products explicitly aimed at preventing and treating microbial infections in animals, thus securing animal health and improving productivity in livestock for food production. This market is necessitated by the heightened risk of disease spread in animal populations, the need to enhance growth rates and feed efficiency, and an increasing global demand for animal-derived food products. Its application spans across veterinary medicine, livestock management, pet care, and aquaculture, with end-users ranging from farmers and veterinarians to pharmaceutical manufacturers. Market growth is driven by rising awareness of animal health issues, advancements in veterinary medicine, and growing global meat consumption. However, significant opportunities lie in emerging economies where livestock industries are concurrently expanding with urbanization, particularly in Asia-Pacific and South America. Key influencing growth factors include technological innovation in antimicrobial and alternative products, regulatory frameworks encouraging reduced antibiotic use, and increased investment in veterinary healthcare. Conversely, market growth faces challenges such as stringent regulations, rising antibiotic resistance concerns, and growing advocacy for antibiotic-free and organic farming. Innovations in molecular diagnostics and precision medicine for tailored treatment, coupled with the development of alternative products such as probiotics and herbal antimicrobials, present potential areas for business expansion. Insights into the market nature reveal a trend towards integrated health management solutions involving collaboration across the food supply chain to ensure sustainability and compliance. Adapting to regulatory changes, investing in R&D for novel and sustainable products, and enhancing strategic partnerships with stakeholders across the animal health spectrum are recommended strategies to navigate market challenges while optimizing growth potential. Overall, the future outlook underscores a balance between advancing animal health solutions and mitigating public health concerns related to antimicrobial resistance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Antibiotics & Antimicrobials Market

The Animal Antibiotics & Antimicrobials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for livestock products and strong demand for penicillin based antibiotics
  • Increasing government involvement in countering animal diseases outbreaks
  • Growing huge capital investment for the development of drugs for animal diseases
• Market Restraints
  • Concerns regarding resistance to antibiotic stringent regulatory approvals
• Market Opportunities
  • Accelerating advanced research and development facilities, and new drug development activities
  • Growing focus towards sustainability of new antimicrobials
• Market Challenges
  • Availability of substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Animal Antibiotics & Antimicrobials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Antibiotics & Antimicrobials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Antibiotics & Antimicrobials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Antibiotics & Antimicrobials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Antibiotics & Antimicrobials Market

A detailed market share analysis in the Animal Antibiotics & Antimicrobials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Antibiotics & Antimicrobials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Antibiotics & Antimicrobials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Antibiotics & Antimicrobials Market

A strategic analysis of the Animal Antibiotics & Antimicrobials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibiotics & Antimicrobials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Antibiotics and Antimicrobial.
• Based on Mode of Delivery, market is studied across Injections and Oral.
• Based on Form, market is studied across Powders & Tablets and Solutions.
• Based on Type of Animal, market is studied across Companion Animals and Food-Producing Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Food-Producing Animals is further studied across Cattle, Pigs, Poultry, and Sheep & Goats.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for livestock products and strong demand for penicillin based antibiotics
    • 5.1.1.2. Increasing government involvement in countering animal diseases outbreaks
    • 5.1.1.3. Growing huge capital investment for the development of drugs for animal diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns regarding resistance to antibiotic stringent regulatory approvals
  • 5.1.3. Opportunities
    • 5.1.3.1. Accelerating advanced research and development facilities, and new drug development activities
    • 5.1.3.2. Growing focus towards sustainability of new antimicrobials
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of substitutes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing need for antibiotics for disease prevention and treatment
  • 5.2.2. Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
  • 5.2.3. Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
  • 5.2.4. Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Antibiotics & Antimicrobials Market, by Product

• 6.1. Introduction
• 6.2. Antibiotics
• 6.3. Antimicrobial

7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery

• 7.1. Introduction
• 7.2. Injections
• 7.3. Oral

8. Animal Antibiotics & Antimicrobials Market, by Form

• 8.1. Introduction
• 8.2. Powders & Tablets
• 8.3. Solutions

9. Animal Antibiotics & Antimicrobials Market, by Type of Animal

• 9.1. Introduction
• 9.2. Companion Animals
  • 9.2.1. Cats
  • 9.2.2. Dogs
  • 9.2.3. Horses
• 9.3. Food-Producing Animals
  • 9.3.1. Cattle
  • 9.3.2. Pigs
  • 9.3.3. Poultry
  • 9.3.4. Sheep & Goats

10. Americas Animal Antibiotics & Antimicrobials Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Animal Antibiotics & Antimicrobials Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Animal Antibiotics & Antimicrobials Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Zoetis Demonstrates Canine Innovation with Commercial Launch of Librela (bedinvetmab injection) in the U.S.
  • 13.3.2. Huvepharma Returns The Only FDA-Approved Triple-Sulfa Medication To US Market
  • 13.3.3. Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. American Regent Inc.
• 2. Ayurvet
• 3. Bayer AG
• 4. Boehringer Ingelheim GmbH
• 5. Ceva Sante Animale
• 6. Chanelle Pharma
• 7. Dechra Pharmaceuticals PLC
• 8. Eco Animal Health Group PLC
• 9. Elanco Animal Health Incorporated
• 10. Eli Lilly and Company
• 11. Endovac Animal Health, LLC
• 12. Hester Biosciences Limited
• 13. Hipra Laboratories, S.A.
• 14. Inovet Group
• 15. Neogen Corporation
• 16. Norbrook Laboratories Ltd.
• 17. Novartis AG
• 18. Phibro Animal Health Corporation
• 19. Sanofi-Aventis Groupe S.A.
• 20. Tianjin Ringpu Biotechnology Co., Ltd.
• 21. Vetoquinol S.A.
• 22. Virbac S.A.
• 23. Zoetis, Inc.
• 24. Zydus Pharmaceuticals, Inc.